From biomedcentral.com
()
Cervical Cancer Virus
Share news and information about cervical cancer and current research into the virus that can cause cervical cancer.
Background:
Recently published results from a large randomized trial (Canadian Cervical Cancer Screening Trial study group) suggest that human papillomavirus testing followed by Pap smear-based triage for human papillomavirus positive women may be an effective way to screen women for cervical cancer. We determined the potential cost-effectiveness of including human papillomavirus tests for cervical cancer screening for Canada and three...
- NICE Recommends Topotecan For Cervical Cancer (medicalnewstoday.com)
Results of the FDA pivotal clinical trial for the LightTouch™ Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI).
From medicalnewstoday.com
()
- Cervical Cancer Vaccine Still Questioned (feedburner.com)
- How Medical Center Research Led To New Cervical Cancer Vaccine (medicalnewstoday.com)
- Panel recommends 2nd cervical cancer vaccine (salon.com)
Preventing cervical cancer not only done with vaccinations and pap smears. Vaccination is often constrained expensive. While regular Pap smears were often not easy to do. You have to adjust the doctor schedule with your own schedule and of course go to the hospital or clinic can be ate its own time.
From del.icio.us
()
- Cervical cancer vaccine approved for use in boys (nydailynews.com)
- Program to address breast and cervical cancers (suburbanchicagonews.com)
- Doctors push HPV vaccination for teens to protect against cervical cancer... (postcrescent.com)
The study estimates the clinical benefits and cost effectiveness of cervical cancer vaccination in a cohort of 12-year old Canadian females. The indirect effect of vaccination, via herd protection, is also estimated. The results show a significant reductions in cervical cancer and high cost-effectiveness of the program.
More perspectives...
From del.icio.us
()
NEW YORK (Reuters Health) - Because the prevalence of two high-risk types of human papillomavirus (HPV) may be greater than previously estimated, vaccination may provide wider protection against invasive cervical cancer than was thought, UK researchers report in the November 15th issue of the International Journal of Cancer.
From rehabpub.com
()
- Confusion surrounds HPV vaccine for men (edgedallas.com)
There has been a rapid and steep decline in new cases of genital warts in Australia since the human papillomavirus (HPV) vaccination became available, reveals research published ahead of print in the journal Sexually Transmitted Infections. But the vaccine used in Australia is Gardasil, which targets HPV types 6,11, 16 and 18.
From medicalnewstoday.com
()
- Safeguard (dailyorange.com)
In 2002 and 2003, screening guidelines for the cervical cancer-detecting Pap test were changed significantly, yet fewer than one-third of U.S. primary care physicians follow those guidelines, according to a recent study.
From news.health.com
()
- Many doctors overuse Pap testing: survey (reuters.com)
